XML 24 R10.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Note 4 - Marketable Equity Securities | 12 Months Ended
--- | ---
Dec. 31, 2023
Notes to Financial Statements |
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] |
4. | MARKETABLE EQUITY SECURITIES
The Company accounts for its marketable securities in accordance with ASC Topic 321, Investments - Equity Securities. ASC Topic 321 requires companies to measure equity investments at fair value, with changes in fair value recognized in net income. The Company’s investments in marketable securities consist of equity securities with readily determinable fair values. The cost of securities sold is based on the specific identification method, and interest and dividends on securities are included in non-operating income (expense). Marketable equity securities are carried at fair value, with changes in fair market value included in the determination of net income. The fair market value of marketable equity securities is determined based on quoted market prices in active markets. See Note 18 – Fair Value of Financial Instruments for additional information regarding the valuation of marketable equity securities. The following table sets forth cost, market value and unrealized gain on equity securities classified as available-for-sale as of December 31, 2023 and 2022.
|  | 2023 |  |  | 2022 |
|  | (in thousands) |
Available-for-sale securities: |  |  |  |  |  |  |  |
Fair market value |  | $ | 43,203 |  |  | $ | 41,728 |
Cost |  |  | 30,294 |  |  |  | 30,350 |
Unrealized gain |  | $ | 12,909 |  |  | $ | 11,378 |
The following table sets forth the gross unrealized gains and losses on the Company’s marketable securities as of December 31, 2023 and 2022.
|  | 2023 |  |  | 2022 |
|  | (in thousands) |
Available-for-sale securities: |  |  |  |  |  |  |  |
Gross unrealized gains |  | $ | 15,539 |  |  | $ | 13,478 |
Gross unrealized losses |  |  | 2,630 |  |  |  | 2,100 |
Net unrealized gains |  | $ | 12,909 |  |  | $ | 11,378 |
For the years ended December 31, 2023, 2022 and 2021, the Company recognized dividends of approximately $1,557,000, $1,539,000 and $1,448,000 in non-operating income in its consolidated statements of operations, respectively. The following table shows the Company’s net realized (losses) gains during 2023, 2022 and 2021 on certain marketable equity securities.
|  | 2023 |  |  | 2022 |  |  | 2021 |
|  | (in thousands) |
Realized (losses) gains: |  |  |  |  |  |  |  |  |  |  |  |
Sale proceeds |  | $ | 343 |  |  | $ | - |  |  | $ | 3,109 |
Cost of securities sold |  |  | 255 |  |  |  | - |  |  |  | 3,199 |
Realized (losses) / gains |  | $ | 88 |  |  | $ | - |  |  | $ | (90 | )
At December 31, 2023, the Company’s investments’ approximate fair value of securities in a loss position and related gross unrealized losses were $8,099,000 and $2,630,000, respectively. At December 31, 2022, the Company’s investments’ approximate fair value of securities in a loss position and related gross unrealized losses were $7,875,000 and $2,100,000, respectively. The market value of the Company’s equity securities are periodically used as collateral against any outstanding margin account borrowings. At December 31, 2023, the Company had no outstanding borrowings under its margin account. At December 31, 2022, the company had outstanding borrowings of $914,000 under its margin account, which was reflected in accrued expenses. The interest rate on margin account borrowings were 4.92% as of December 31, 2022, respectively.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//320/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph (b) -Publisher SEC Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//946-320/tableOfContent Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 940 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//940-320/tableOfContent Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//942-320/tableOfContent + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration